PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+13.82%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.46B
AUM Growth
+$2.46B
(-4%)
Cap. Flow
-$342M
Cap. Flow
% of AUM
-13.91%
Top 10 Holdings %
Top 10 Hldgs %
59.49%
Holding
158
New
14
Increased
43
Reduced
54
Closed
16
Top Buys
| 1 |
Ball Corp
BALL
|
$31.9M |
| 2 |
TransUnion
TRU
|
$13.6M |
| 3 |
Visa
V
|
$7.21M |
| 4 |
Baxter International
BAX
|
$6.57M |
| 5 |
Monster Beverage
MNST
|
$4M |
Top Sells
| 1 |
Microchip Technology
MCHP
|
$126M |
| 2 |
Carlisle Companies
CSL
|
$83.9M |
| 3 |
NXP Semiconductors
NXPI
|
$69.5M |
| 4 |
Pinduoduo
PDD
|
$32.1M |
| 5 |
RH
RH
|
$25.2M |
Sector Composition
| 1 | Consumer Discretionary | 20.74% |
| 2 | Energy | 15.66% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 14.09% |
| 5 | Technology | 13.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INBX
51
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $6.37M | 0.26% |
167,763
-61,273
| -27% | -$2.33M |
|
52
Gossamer Bio
GOSS
$587M
| $6.35M | 0.26% |
6,954,110
+1,596,332
| +30% | +$1.46M |
|
53
Biogen
BIIB
$20.8B
| $6.22M | 0.25% |
24,020
-24
| -0.1% | -$6.21K |
|
54
Allegion
ALLE
$14.4B
| $5.57M | 0.23% |
43,948
+12,441
| +39% | +$1.58M |
|
55
Chewy
CHWY
$16.8B
| $4.74M | 0.19% |
200,448
+133,066
| +197% | +$3.14M |
|
56
Zymeworks
ZYME
$1.07B
| $4.26M | 0.17% |
409,839
| – | – |
|
|
57
Monster Beverage
MNST
$62B
| $4M | 0.16% |
+69,386
| New | +$4M |
|
58
Merus
MRUS
$5.04B
| $3.91M | 0.16% |
142,029
| – | – |
|
59
Arcus Biosciences
RCUS
$1.24B
| $3.9M | 0.16% |
204,398
| – | – |
|
60
Netflix
NFLX
$521B
| $3.86M | 0.16% |
7,938
+759
| +11% | +$370K |
|
61
Amazon
AMZN
$2.41T
| $3.75M | 0.15% |
24,663
+2,050
| +9% | +$311K |
|
62
Absci
ABSI
$356M
| $3.52M | 0.14% |
837,596
-469,072
| -36% | -$1.97M |
|
63
Broadcom
AVGO
$1.42T
| $3.49M | 0.14% |
+3,126
| New | +$3.49M |
|
64
Wave Life Sciences
WVE
$1.27B
| $3.31M | 0.13% |
655,331
+200,000
| +44% | +$1.01M |
|
65
Immatics
IMTX
$662M
| $3.3M | 0.13% |
313,574
+45,363
| +17% | +$478K |
|
66
Structure Therapeutics
GPCR
$1.14B
| $3.14M | 0.13% |
77,093
+24,632
| +47% | +$1M |
|
67
Vera Therapeutics
VERA
$1.47B
| $3.08M | 0.13% |
200,302
| – | – |
|
|
CNTA
68
Centessa Pharmaceuticals
CNTA
$2.13B
| $3.03M | 0.12% |
381,083
+43,539
| +13% | +$347K |
|
69
Arrowhead Research
ARWR
$3.84B
| $2.97M | 0.12% |
97,168
| – | – |
|
70
Veeva Systems
VEEV
$44.4B
| $2.88M | 0.12% |
14,935
+11,423
| +325% | +$2.2M |
|
|
CNTG
71
DELISTED
Centogene N.V. Common Shares
CNTG
| $2.85M | 0.12% |
2,376,442
-708
| -0% | -$850 |
|
72
Cogent Biosciences
COGT
$1.83B
| $2.8M | 0.11% |
475,634
-203
| -0% | -$1.19K |
|
73
Alpha Teknova
TKNO
$227M
| $2.75M | 0.11% |
736,540
-97,989
| -12% | -$365K |
|
|
OMGA
74
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.67M | 0.11% |
886,782
-235
| -0% | -$707 |
|
75
Oracle
ORCL
$628B
| $2.55M | 0.1% |
24,143
| – | – |
|